Comparison of two treatments in the presence of competing risks
Authors:
- 31 May 2020
- journal article
- research article
- Published by Wiley in Pharmaceutical Statistics
- Vol. 19 (6) , 746-762
Abstract
Summary: Competing risks data arise frequently in clinical trials, and a common problem encountered is the overall homogeneity between two groups. In competing risks analysis, when the proportional subdistribution hazard assumption is violated or two cumulative incidence function (CIF) curves cross; currently, the most commonly used testing methods, for example, the Gray test and the Pepe and Mori test, may lead to a significant loss of statistical testing power. In this article, we propose a testing method based on the area between the CIF curves (ABC). The ABC test captures the difference over the whole time interval for which survival information is available for both groups and is not based on any special assumptions regarding the underlying distributions. The ABC test was also extended to test short‐term and long‐term effects. We also consider a combined test and a two‐stage procedure based on this new method, and a bootstrap resampling procedure is suggested in practice to approximate the limiting distribution of the combined test and two‐stage test. An extensive series of Monte Carlo simulations is conducted to investigate the power and the type I error rate of the methods. In addition, based on our simulations, our proposed TS, Comb, and ABC tests have a relatively high power in most situations. In addition, the methods are illustrated using two different datasets with different CIF situations.Keywords
Funding Information
- National Natural Science Foundation of China (81673268, 81903411)
- Natural Science Foundation of Guangdong Province (2017A030313812, 2018A030313849)
This publication has 23 references indexed in Scilit:
- Weighted comparison of two cumulative incidence functions with R-CIFsmry packageComputer Methods and Programs in Biomedicine, 2014
- Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2013
- On the Importance of Accounting for Competing Risks in Pediatric Cancer Trials Designed to Delay or Avoid Radiotherapy: I. Basic Concepts and First AnalysesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Competing Risk of Death: An Important Consideration in Studies of Older AdultsJournal of the American Geriatrics Society, 2010
- Comparison of failure probabilities in the presence of competing risksJournal of Statistical Computation and Simulation, 2008
- Two-sample tests of the equality of two cumulative incidence functionsComputational Statistics & Data Analysis, 2007
- Kaplan—meier, marginal or conditional probability curves in summarizing competing risks failure time data?Statistics in Medicine, 1993
- Inference for Events with Dependent Risks in Multiple Endpoint StudiesJournal of the American Statistical Association, 1991
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- Nonparametric Estimation of Partial Transition Probabilities in Multiple Decrement ModelsThe Annals of Statistics, 1978